Table 4: Clinical characteristics of B- and T-lineage ALL according to CD34 expression


 

B-lineage ALL, n=178

T-lineage ALL, n=33

 

 

 

CD34+
n (%)

CD34-
n (%)

p value

 

CD34+
n (%)

CD34-
n (%)

p value

 

Sex

 

 

 

 

 

 

 

 

 Male

100(56)

55 (55)

45 (45)

0.22

25(76)

7(28)

18(72)

0.09

 Female

78 (44)

50 (64)

28 (36)

 

8 (24)

0 (0)

8(100)

 

Age

 

 

 

 

 

 

 

 

 1-9 years

139(78)

86 (62)

53 (38)

0.14

26(79)

5 (19)

21(81)

0.59

<1 &>10 years

39 (22)

19 (49)

20 (51)

 

7 (21)

2 (29)

5 (71)

 

WBC

 

 

 

 

 

 

 

 

<50.000/ mm3

148(83)

88 (60)

60 (40)

0.78

21(64)

5 (24)

16(76)

0.63

>50.000/ mm3

30 (17)

17 (57)

13 (43)

 

12(36)

2 (17)

10(83)

 

FAB

 

 

 

 

 

 

 

 

 ALL-L1

145(82)

84 (58)

61 (42)

0.55

30(91)

6(20)

24(80)

0.59

 ALL-L2

33 (18)

21 (64)

12 (36)

 

3 (9)

1 (33)

2 (67)

 

Risk*

 

 

 

 

 

 

 

 

 SR

94 (53)

63 (67)

31 (33)

0.02

0

0 (0)

0 (0)

 

 HR

84 (47)

42 (50)

42 (50)

 

33(100)

7 (21)

26(79)

 


*Risk Classification based on NCI criteria

 

Supriyadi et al.Journal of Cancer Therapeutics and Research  2012 1:20DOI : 10.7243/2049-7962-1-20